De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Tenet Healthcare Toekomstige groei

Future criteriumcontroles 0/6

De winst van Tenet Healthcare zal naar verwachting dalen met 32.1% per jaar, terwijl de jaarlijkse omzet naar verwachting zal groeien met 3.6% per jaar. De winst per aandeel zal naar verwachting dalen met 32.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 12.8% zijn.

Belangrijke informatie

-32.1%

Groei van de winst

-32.6%

Groei van de winst per aandeel

Healthcare winstgroei	19.3%
Inkomstengroei	3.6%
Toekomstig rendement op eigen vermogen	12.8%
Dekking van analisten	Good
Laatst bijgewerkt	10 Sep 2024

Recente toekomstige groei-updates

Recent updates

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Jul 11

Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)

Jun 17

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

May 21

Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Apr 30

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Mar 18

Tenet Healthcare: Shrinking To Grow

Feb 04

Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

Dec 18

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Nov 15

Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt

Oct 13

Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Aug 02

Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now

Jul 28

Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

Apr 13

USPI and Providence extend hands to aid ambulatory surgical services

Feb 09

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Jan 31

Tenet Healthcare: Compressed Multiples Appear Justified

Jan 27

Winst- en omzetgroeiprognoses

NYSE:THC - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	22,713	1,091	1,919	2,542	15
12/31/2025	21,696	1,006	1,940	2,373	18
12/31/2024	20,839	2,896	2,679	1,968	17
6/30/2024	20,910	2,755	1,891	2,660	N/A
3/31/2024	20,895	2,619	1,755	2,511	N/A
12/31/2023	20,548	611	1,623	2,374	N/A
9/30/2023	20,170	469	1,138	1,971	N/A
6/30/2023	19,905	499	961	1,783	N/A
3/31/2023	19,453	414	462	1,304	N/A
12/31/2022	19,174	410	321	1,083	N/A
9/30/2022	19,040	558	243	1,019	N/A
6/30/2022	19,133	875	414	1,136	N/A
3/31/2022	19,449	957	570	1,262	N/A
12/31/2021	19,485	915	910	1,568	N/A
9/30/2021	19,544	1,079	1,137	1,657	N/A
6/30/2021	19,207	434	1,323	1,818	N/A
3/31/2021	17,901	402	3,333	3,812	N/A
12/31/2020	17,640	399	2,867	3,407	N/A
9/30/2020	17,531	-18	2,929	3,481	N/A
6/30/2020	17,542	-48	2,685	3,307	N/A
3/31/2020	18,454	-112	692	1,352	N/A
12/31/2019	18,479	-226	563	1,233	N/A
9/30/2019	18,292	-228	258	963	N/A
6/30/2019	18,213	-10	197	882	N/A
3/31/2019	18,159	-10	280	946	N/A
12/31/2018	18,313	101	432	1,049	N/A
9/30/2018	18,672	-117	671	1,290	N/A
6/30/2018	18,769	-474	633	1,260	N/A
3/31/2018	19,065	-554	N/A	1,127	N/A
12/31/2017	19,179	-704	N/A	1,200	N/A
9/30/2017	19,061	-553	N/A	416	N/A
6/30/2017	19,324	-196	N/A	377	N/A
3/31/2017	19,390	-184	N/A	597	N/A
12/31/2016	19,621	-187	N/A	558	N/A
9/30/2016	19,787	-208	N/A	1,042	N/A
6/30/2016	19,630	-227	N/A	1,255	N/A
3/31/2016	19,254	-243	N/A	1,230	N/A
12/31/2015	18,634	-142	N/A	1,026	N/A
9/30/2015	18,073	19	N/A	1,054	N/A
6/30/2015	17,556	57	N/A	793	N/A
3/31/2015	17,101	107	N/A	649	N/A
12/31/2014	16,603	34	N/A	687	N/A
9/30/2014	16,023	-44	N/A	723	N/A
6/30/2014	14,256	-21	N/A	708	N/A
3/31/2014	12,641	-64	N/A	602	N/A
12/31/2013	11,087	-123	N/A	589	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De winst van THC zal naar verwachting de komende 3 jaar dalen ( -32.1% per jaar).

Winst versus markt: De winst van THC zal naar verwachting de komende 3 jaar dalen ( -32.1% per jaar).

Hoge groeiwinsten: De winst van THC zal naar verwachting de komende 3 jaar dalen.

Omzet versus markt: De omzet van THC ( 3.6% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.7% per jaar).

Hoge groei-inkomsten: De omzet van THC ( 3.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen THC zal naar verwachting over 3 jaar laag zijn ( 12.8 %).

Tenet Healthcare Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 12% to US$162

Tenet Healthcare Corporation Provides Earnings Guidance for the Third Quarter and Full Year of 2024

Consensus EPS estimates increase by 70%

Price target increased by 9.7% to US$123

Tenet Healthcare Corporation Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Consensus EPS estimates increase by 144%, revenue downgraded

Recent updates

Tenet Healthcare Corporation to Report Q3, 2024 Results on Oct 29, 2024

Tenet Healthcare: Becoming A Very Healthy Business

Insider recently sold US$1.9m worth of stock

Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price

Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)

Chairman & CEO recently sold US$15m worth of stock

Chairman & CEO notifies of intention to sell stock

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Independent Director recently sold US$2.9m worth of stock

Independent Director notifies of intention to sell stock

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 12% to US$162

Tenet Healthcare Corporation Provides Earnings Guidance for the Third Quarter and Full Year of 2024

Tenet Healthcare Corporation (NYSE:THC) announces an Equity Buyback for $1,500 million worth of its shares.

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued

Tenet Healthcare Corporation to Report Q2, 2024 Results on Jul 24, 2024

Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)

Lead Independent Director recently sold US$3.2m worth of stock

Lead Independent Director notifies of intention to sell stock

With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case

Investor sentiment improves as stock rises 23%

Consensus EPS estimates increase by 70%

EVP, Chief Administrative Officer recently sold US$946k worth of stock

EVP, Chief Administrative Officer notifies of intention to sell stock

Price target increased by 9.7% to US$123

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Tenet Healthcare Corporation Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit

Tenet Healthcare Corporation, Annual General Meeting, May 22, 2024

Tenet Healthcare Corporation, Annual General Meeting, May 22, 2024

Adventist Health System/West completed the acquisition of Sierra Vista Hospital, Inc and Twin Cities Community Hospital, Inc. from Tenet Healthcare Corporation (NYSE:THC).

UCI Medical Center acquired Fountain Valley Regional Hospital, Lakewood Regional Medical Center, Los Alamitos Medical, and Placentia-Linda Hospital from Tenet Healthcare Corporation (NYSE:THC).

Tenet Healthcare Corporation to Report Q1, 2024 Results on Apr 30, 2024

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Independent Director recently sold US$1.4m worth of stock

Independent Director notifies of intention to sell stock

Insider recently sold US$1.8m worth of stock

Chairman & CEO exercised options and sold US$2.3m worth of stock

Adventist Health System/West agreed to acquire Sierra Vista Hospital, Inc and Twin Cities Community Hospital, Inc. from Tenet Healthcare Corporation (NYSE:THC) for $550 million.

Independent Director recently sold US$715k worth of stock

New minor risk - Earnings quality

Consensus EPS estimates increase by 144%, revenue downgraded

Price target increased by 17% to US$104

Tenet Healthcare Corporation Provides Consolidated Earnings Guidance for the First Quarter and Full Year of 2024

Full year 2023 earnings: EPS exceeds analyst expectations

Tenet Healthcare: Shrinking To Grow

Novant Health, Inc. completed the acquisition of Coastal Carolina Hospital, East Cooper Medical Center and Hilton Head Hospital and Certain Related Operations in South Carolina from Tenet Healthcare Corporation (NYSE:THC) and Hilton Head Regional Healthcare, L.L.C.

Tenet Healthcare Corporation to Report Q4, 2023 Results on Feb 08, 2024

Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

Tenet Healthcare Corporation Appoints Vineeta Agarwala to Board of Directors, Member of the Quality, Compliance, and Ethics Committee

Independent Director recently sold US$400k worth of stock

Novant Health, Inc. signed a definitive agreement to acquire Coastal Carolina Hospital, East Cooper Medical Center and Hilton Head Hospital and Certain Related Operations in South Carolina from Tenet Healthcare Corporation (NYSE:THC) for $2.4 billion.

Investor sentiment improves as stock rises 18%

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Price target decreased by 7.4% to US$84.81

Third quarter 2023 earnings: EPS misses analyst expectations

Tenet Healthcare Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year 2023

Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt

Tenet Healthcare Corporation to Report Q3, 2023 Results on Oct 30, 2023

Tenet Healthcare Corporation Announces Retirement of Daniel Cancelm as Executive Vice President, Effective December 31, 2023

Tenet Healthcare Corporation Appoints Senator Roy Blunt to Board of Directors

Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Second quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat

Tenet Healthcare Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023

Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now

Tenet Healthcare Corporation to Report Q2, 2023 Results on Jul 31, 2023

Insider notifies of intention to sell stock

Tenet Healthcare Corporation Appoints Stephen H. Rusckowski to its Board of Directors

EVP, Chief Administrative Officer recently sold US$1.5m worth of stock